Insider Trading Activity - Foresite Capital Fund V L.P.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Foresite Capital Fund V L.P.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-07-01 Purchase	2024-07-03 9:30 pm	ALUMIS INC.	ALMS	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Management VI LLC Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner	2,500,000	$16	$40,000,000	5,379,140 (Indirect)	View
2023-07-17 Purchase	2023-07-19 2:54 pm	Theseus Pharmaceuticals Inc.	THRX	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner	700,000	$2.97	$2,079,000	1,385,825 (Indirect)	View
2023-05-08 Purchase	2023-05-10 5:42 pm	Kinnate Biopharma Inc.	KNTE	Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC 10% Owner	1,780,000	$2.8	$4,984,000	10,192,354 (Indirect)	View
2023-04-05 Purchase	2023-04-06 9:08 pm	PARDES BIOSCIENCES INC.	PRDS	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner	773,952	$1.5	$1,160,928	13,583,762 (Indirect)	View
2022-12-29 Purchase	2023-01-03 4:24 pm	Theseus Pharmaceuticals Inc.	THRX	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner	500,000	$5	$2,500,000	1,209,275 (Indirect)	View
2022-12-01 Purchase	2022-12-05 4:24 pm	PARDES BIOSCIENCES INC.	PRDS	Foresite Capital Management V LLC Tananbaum James B. Foresite Capital Fund V L.P. 10% Owner	637,420	$0.85	$541,807	12,809,810 (Indirect)	View
2021-12-22 Purchase	2021-12-23 4:52 pm	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	325,000	$10	$3,250,000	325,000 (Indirect)	View
2021-02-19 Purchase	2021-02-23 5:34 pm	FS Development Corp. II	FSII	FS Development Holdings II LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Tananbaum James B. 10% Owner	602,500	$10	$6,025,000	602,500 (Direct)	View
2020-08-14 Purchase	2020-10-19 8:49 pm	FS Development Corp.	FSDC	FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Tananbaum James B. 10% Owner	441,500	$10	$4,415,000	441,500 (Direct)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2024-07-01 Conversion	2024-07-03 9:30 pm	N/A N/A	ALUMIS INC.	ALMS	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Management VI LLC Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner	11,476,484	$0	5,379,140 (Indirect)	View
Ownership	2024-06-27 9:30 pm	N/A N/A	ALUMIS INC.	ALMS	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Management VI LLC Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner	0	$0	12,652,954 (Indirect)	View
2024-04-03 Disposition	2024-04-05 2:15 pm	N/A N/A	Kinnate Biopharma Inc.	KNTE	Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner	13,718,311	$0	0 (Indirect)	View
2023-08-31 Disposition	2023-08-31 5:22 pm	N/A 2033-05-31	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. FS Development Holdings II LLC Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Fund V L.P. President and CEO 10% Owner	16,963,146	$0	2,000 (Direct)	View
2023-08-31 Other	2023-08-31 5:22 pm	N/A N/A	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. FS Development Holdings II LLC Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Fund V L.P. President and CEO 10% Owner	1,000	$0	2,000 (Indirect)	View
2023-02-17 Other	2023-02-22 2:49 pm	N/A N/A	Kinnate Biopharma Inc.	KNTE	Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC 10% Owner	1,100,000	$0	13,038,311 (Indirect)	View
Ownership	2022-06-13 5:15 pm	N/A N/A	Theseus Pharmaceuticals Inc.	THRX	Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner	0	$0	4,294,621 (Indirect)	View
2021-12-23 Option Award(A)	2022-06-10 4:17 pm	N/A 2031-12-22	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	75,000	$0	75,000 (Direct)	View
2021-12-23 Conversion(A)	2021-12-30 4:30 pm	N/A N/A	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	4,941,250	$0	4,941,250 (Indirect)	View
2021-12-23 Option Award	2021-12-28 4:30 pm	N/A 2031-12-22	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	7,834,072	$0	8,761,572 (Direct)	View
2021-12-23 Conversion	2021-12-28 4:30 pm	N/A N/A	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	4,873,750	$0	8,761,572 (Indirect)	View
2021-12-23 Option Award	2021-12-28 4:30 pm	N/A N/A	PARDES BIOSCIENCES INC.	PRDS	Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner	1,000,000	$10	8,761,572 (Indirect)	View
2021-11-01 Other	2021-11-03 4:17 pm	N/A N/A	Aclaris Therapeutics Inc.	ACRS	Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner	1,963,180	$0	6,628,733 (Indirect)	View
Ownership	2021-02-16 9:38 pm	N/A N/A	FS Development Corp. II	FSII	FS Development Holdings II LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Director by deputization Director 10% Owner	0	$0	5,031,250 (Direct)	View
Ownership	2021-02-10 6:00 pm	N/A N/A	Aclaris Therapeutics Inc.	ACRS	Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner	0	$0	6,612,181 (Indirect)	View
2021-02-05 Conversion	2021-02-09 3:04 pm	N/A N/A	Gemini Therapeutics Inc.	GMTX	FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director by Deputization Director 10% Owner	2,928,750	$0	3,370,250 (Direct)	View
2021-02-05 Option Award	2021-02-09 3:04 pm	N/A N/A	Gemini Therapeutics Inc.	GMTX	FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director by Deputization Director 10% Owner	1,500,000	$10	3,370,250 (Direct)	View
2020-12-07 Conversion	2020-12-09 1:35 pm	N/A N/A	Kinnate Biopharma Inc.	KNTE	Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner	19,675,448	$0	291,667 (Indirect)	View
2020-12-03 Option Award	2020-12-04 8:57 pm	N/A N/A	Kinnate Biopharma Inc.	KNTE	Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner	1,000,000	$20	125,000 (Indirect)	View
Ownership	2020-12-03 06:03 am	N/A N/A	Kinnate Biopharma Inc.	KNTE	Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner	0	$0	9,838,311 (Indirect)	View
Ownership(A)	2020-08-19 9:14 pm	N/A N/A	FS Development Corp.	FSDC	FS Development Holdings LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC 10% Owner	0	$0	3,018,750 (Direct)	View

(A) Indicate amendment filing.

Insider Trading & Ownership - Foresite Capital Fund V L.P.